<?xml version="1.0" encoding="utf-8"?>
			<journal>
			<title>Avicenna Journal of Phytomedicine</title>
			<title_fa></title_fa>
			<short_title></short_title>
			<subject>Medical Sciences</subject>
			<web_url>https://ajp.mums.ac.ir/</web_url>
			<journal_hbi_system_id>0</journal_hbi_system_id>
			<journal_hbi_system_user></journal_hbi_system_user>
			<journal_id_issn>2228-7930</journal_id_issn>
			<journal_id_issn_online>2228-7949</journal_id_issn_online>
			<journal_id_pii></journal_id_pii>
			<journal_id_doi></journal_id_doi>
			<journal_id_iranmedex></journal_id_iranmedex>
			<journal_id_magiran></journal_id_magiran>
			<journal_id_sid></journal_id_sid>
			<journal_id_nlai></journal_id_nlai>
			<journal_id_science></journal_id_science>
			<language>en</language>
			<pubdate>
				<type>jalali</type>
				<year>0</year>
				<month>0</month>
				<day>1</day>
			</pubdate>
			<pubdate>
				<type>gregorian</type>
				<year>2026</year>
				<month>3</month>
				<day>1</day>
			</pubdate>
			<volume>16</volume>
			<number>2</number>
			<publish_type>online</publish_type>
			<publish_edition>1</publish_edition>
			<article_type>fulltext</article_type>
			<articleset><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Almond for mild to moderate Alzheimer’s disease: A randomized clinical trial</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Short communication</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective: Almonds are frequently advised as brain tonic and memory enhancers in Persian medicine. There is also scientific evidence to support the effects of almond on memory. This study was designed to assess the effects of almond (Prunus dulcis) on memory and cognitive functions in patients with Alzheimer’s disease (AD).Materials and Methods: In this randomized controlled trial, 60 AD patients with mild to moderate cognitive disorder were randomly allocated into an almond group (10 g/day powdered sweet almond plus 1 teaspoon of powdered rock candy along with their previous prescriptions), or the control group (continue previous prescriptions) for 3 months.  The Mini–mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Clinical Dementia Rating (CDR), and Functional Assessment Staging (FAST) questionnaires were completed at the beginning and the end of the study. The sleep quality was also assessed by the Pittsburg Sleep Quality Index (PSQI).Results: Thirty participants in each group completed the study, and were analyzed. Age was 71.86±8.04 years in the almond group and 71.3±7.18 years in the control group (p=0.775). Duration of memory deficit was 2.8±0.92 and 3±1.2 months in the almond and control group, respectively (p=0.473). The orientation scale of the MMSE (p=0.024), MOCA (p=0.001), memory scale of MOCA (p=0.005), FAST (p=0.032), and PSQI (p&lt;0.001) in the almond group were significantly improved compared to those in the control group.Conclusion: Almond is a probable safe intervention for memory and sleep enhancement in AD patients. Conducting studies with larger samples, longer follow-up periods, and different control groups are suggested. ]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Alzheimer’s disease, Dementia, Almond, Persian Medicine, Herbal Medicine</keyword>
				<start_page>195</start_page>
				<end_page>206</end_page>
				<web_url>https://ajp.mums.ac.ir/article_26297.html</web_url>
			<author_list><author>
				<first_name>Mohsen</first_name>
				<middle_name></middle_name>
				<last_name>Mohajeri</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mo_mohajeri@yahoo.com</email>
				<code>115441</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Traditional Medicine,  Institute for Studies in Medical History, Persian and Complementary Medicine, School of Persian Medicine, Iran University of Medical Sciences, Tehran, IranDepartment of Traditional Medicine, School</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Fataneh</first_name>
				<middle_name></middle_name>
				<last_name>Hashem-Dabaghian</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>dabaghian.f@iums.ac.ir</email>
				<code>115442</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Traditional Medicine, Institute for Studies in Medical History, Persian and Complementary Medicine, School of Persian Medicine, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Shima</first_name>
				<middle_name></middle_name>
				<last_name>Raeesi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>shraeesi@sina.tums.ac.ir</email>
				<code>115443</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Geriatric Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Somaye</first_name>
				<middle_name></middle_name>
				<last_name>Mahroozade</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>dr.mahroozade@gmail.com</email>
				<code>115444</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Traditional Medicine, Institute for Studies in Medical History, Persian and Complementary Medicine, School of Persian Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Antioxidant, anti-inflammatory and cytoprotective effects of crocin, a bioactive constituent of saffron, in Alzheimer’s and Parkinson’s diseases with a focus on molecular mechanisms: A systematic review</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Review Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective: This study assessed the neuroprotective effects of crocin one of the main bioactive compounds of saffron, in Alzheimer’s and Parkinson’s diseases, by focusing on its anti-oxidative, anti-inflammatory, and cytoprotective properties.Materials and Methods: In this systematic review, we evaluated the efficacy of crocin on in vivo models of Alzheimer’s and Parkinson’s diseases. Using three online literature databases (PubMed, Scopus, and Google Scholar), we identified studies describing the neuroprotective effects of crocin in Alzheimer’s and Parkinson’s diseases. A literature search was carried out using a combination of keywords such as crocin, Alzheimer’s disease, Parkinson’s disease, antioxidant, anti-inflammatory, and cytoprotective. Papers were identified to describe the neuroprotective effects of crocin from 2013 until 2024.Results: The total number of articles included in the present review is 28. Reducing reactive oxygen species (ROS) and malondialdehyde (MDA) and increasing superoxide dismutase (SOD) levels indicate the anti-oxidant effects of crocin. Crocin can show anti-inflammatory activities via decreasing tumor necrosis factor-alpha (TNF-α) and interleukin levels. Crocin can display cytoprotective effects via down-regulation of p- extracellular signal-regulated kinase (ERK)1/2, and augmentation of phosphoinositide 3-kinases (PI3K)/Akt/ mammalian target of rapamycin (mTOR) signaling pathway activity.Conclusion: Finally due to a noticeable efficacy of crocin, it is suggested that crocin can be used as a suitable neuroprotective agent against Alzheimer’s and Parkinson’s diseases.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Crocin Alzheimer’s disease Parkinson’s disease antioxidant anti, inflammatory cytoprotective</keyword>
				<start_page>207</start_page>
				<end_page>228</end_page>
				<web_url>https://ajp.mums.ac.ir/article_26032.html</web_url>
			<author_list><author>
				<first_name>Zahra</first_name>
				<middle_name></middle_name>
				<last_name>Tayarani-Najaran</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>tayaraninz@mums.ac.ir</email>
				<code>114283</code>
				<coreauthor>No</coreauthor>
				<affiliation>Medical Toxicology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
 |Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Elham</first_name>
				<middle_name></middle_name>
				<last_name>Hadipour</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>hadipour_e@guilan.ac.ir</email>
				<code>114284</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Biology, Faculty of Science, University of Guilan, Rasht, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Shirin</first_name>
				<middle_name></middle_name>
				<last_name>Ramazani</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>shirinramezani18@gmail.com</email>
				<code>114285</code>
				<coreauthor>No</coreauthor>
				<affiliation>Healthcare center, Shirvan Health and Treatment Network, North Khorasan University of Medical Sciences, Bojnord, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Leyli</first_name>
				<middle_name></middle_name>
				<last_name>Taghizadeh</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>leylitaghizadeh085@gmail.com</email>
				<code>114286</code>
				<coreauthor>No</coreauthor>
				<affiliation>Imam Khomeini Hospital, Shirvan Health and Treatment Network, North Khorasan University of Medical Sciences, Bojnord, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Elham</first_name>
				<middle_name></middle_name>
				<last_name>Ramazani</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>el.ramazani@yazd.ac.ir</email>
				<code>114287</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Biology, Yazd University, Yazd, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Possible therapeutic effects of Plantago major in women with high menstrual bleeding: A systematic review of randomized clinical trials</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Review Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective: High menstrual bleeding (HMB) is a common issue affecting women&#039;s health, often leading to significant physical and psychological distress. While several medical treatments are available, many women face treatment failures or undesirable side effects, prompting interest in natural remedies. This systematic review aims to evaluate the therapeutic effects of Plantago major on women with high menstrual bleeding, focusing on randomized clinical trials.Materials and Methods: A comprehensive literature search was conducted in various databases such as, PubMed, ScienceDirect, Cochrane Library, and Google Scholar to identify relevant randomized clinical trials assessing the efficacy of Plantago major in reducing menstrual bleeding until July 2024. Various preparations of P. major were utilized in the included studies.Results: Administration of P. major leaf and seed extract significantly reduced both the duration and severity of bleeding. These extracts also led to a decrease in hemoglobin (Hb) and hematocrit (HTC) levels in the intervention group compared to the control group. The rectal suppository of P. major seed extract significantly decreased bleeding during the first 4 hours postpartum compared to the control group. Additionally, vaginal suppositories of P. major leaf extract notably reduced the mean in the pictorial blood loss assessment chart (PBAC) and improved the duration of bleeding in the intervention group.Conclusion: The extracts of P. major seeds and leaves may enhance hematological parameters and reduce both the mean and severity of menstrual bleeding; however, the clinical significance of these findings necessitates further assessment in future trials.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Plantago, Bleeding, Menorrhagia, Heavy menstrual bleeding, Women's health</keyword>
				<start_page>229</start_page>
				<end_page>241</end_page>
				<web_url>https://ajp.mums.ac.ir/article_26360.html</web_url>
			<author_list><author>
				<first_name>Mohammad Reza</first_name>
				<middle_name></middle_name>
				<last_name>Khazdair</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>m.khazdair@yahoo.com</email>
				<code>115706</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Birjand University of Medical Sciences , Ghafari Street, Birjand, South Khorasan, Iran. Tel: +985632395696  Fax: +985631635801</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Majid</first_name>
				<middle_name></middle_name>
				<last_name>Kianmehr</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>majid.kianmehr@gmail.com</email>
				<code>115707</code>
				<coreauthor>No</coreauthor>
				<affiliation>Esfarayen Faculty of Medical Sciences, Esfarayen, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Impact of flavonoid-rich herbal medicines on idiopathic heavy menstrual bleeding: A systematic review and meta-analysis of randomized controlled trials</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Review Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective: Persian medicine has recommended flavonoid-rich plants for idiopathic heavy menstrual bleeding (HMB), highlighting their blood-reducing and antioxidant properties in menorrhagia. We aimed to explore the potential of flavonoid-rich plants as a safe and effective therapy for HMB.Materials and Methods: A systematic search was conducted on 10 databases from inception to July 11, 2023. Randomized controlled trials (RCTs) reporting the use of Persian medicine-recommended plants for idiopathic HMB were included. Outcome measures included the pictorial blood assessment chart (PBAC), duration of bleeding, quality of life, and hemoglobin levels.Results: A total of 12 RCTs involving 425 participants were included in the analysis. The results indicated the potential benefits of plants in terms of PBAC, duration of bleeding, and quality of life. Furthermore, these plants were found to cause a slight statistically significant increase in hemoglobin levels.Conclusion: This study provides valuable insights into the use of the Persian medicine-recommended flavonoid-rich plants for idiopathic HMB. It suggests that flavonoid-rich plants based on Persian medicine may be effective and safe options for idiopathic HMB.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Menorrhagia Idiopathic heavy menstrual bleeding Persian medicine Herbal Medicines Meta, Analysis Systematic review</keyword>
				<start_page>242</start_page>
				<end_page>259</end_page>
				<web_url>https://ajp.mums.ac.ir/article_26057.html</web_url>
			<author_list><author>
				<first_name>Marzieh</first_name>
				<middle_name></middle_name>
				<last_name>Qaraaty</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>gharaaty1387@yahoo.com</email>
				<code>114408</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Traditional Medicine, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Ayesheh</first_name>
				<middle_name></middle_name>
				<last_name>Enayati</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>enayati_phyto@yahoo.com</email>
				<code>114409</code>
				<coreauthor>No</coreauthor>
				<affiliation>Ischemic research Center, Golestan University of Medical Sciences, Gorgan, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>maedeh</first_name>
				<middle_name></middle_name>
				<last_name>rezghi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>maedehrezghi@yahoo.com</email>
				<code>114411</code>
				<coreauthor>No</coreauthor>
				<affiliation>Traditional Medicine and History of Medical Sciences Research Center, Health, Research Institute, Babol University of Medical Sciences, Babol, Iran
Department of Persian Medicine, School of Persian Medicine, Babol University of Medical</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Abdolhalim</first_name>
				<middle_name></middle_name>
				<last_name>Rajabi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>rajabiepid@gmail.com</email>
				<code>114412</code>
				<coreauthor>No</coreauthor>
				<affiliation>Health Management and Social Development Research Center, Faculty of Health, Golestan University of Medical Sciences, Gorgan, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mojgan</first_name>
				<middle_name></middle_name>
				<last_name>Tansaz</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>tansaz_mojgan@yahoo.com</email>
				<code>114413</code>
				<coreauthor>No</coreauthor>
				<affiliation>Departmant of Traditional Medicine, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Masoud</first_name>
				<middle_name></middle_name>
				<last_name>Mohammadi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mohammadi@goums.ac.ir</email>
				<code>114414</code>
				<coreauthor>No</coreauthor>
				<affiliation>Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran.</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Amirhossein</first_name>
				<middle_name></middle_name>
				<last_name>Sahebkar</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>sahebkara@mums.ac.ir</email>
				<code>114410</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Nordihydroguaiaretic acid attenuates TNFα-dependent intercellular adhesion molecule-1 expression in cultured human umbilical vein endothelial cells via targeting TNFα-PI3K-NF-κB-ICAM1 pathway</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Research Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective: During inflammation and oxidative stress, vascular endothelial cell surfaces express high levels of adhesion molecules such as intercellular adhesion molecule 1 (ICAM1) which bind the circulatory leukocytes (e.g. macrophages), through counter receptors LFA/Mac1. The bound leukocytes on sub-endothelial translocation accumulate oxidized lipids and proteins, developing atherosclerotic plaques by foam cell and fatty streak formations. Herewith, nordihydroguaiaretic acid (NDGA) prevails as a polyphenol in the Larrea tridentata plant, with potent antioxidant and anti-inflammatory traits. This study for the first time elucidates that NDGA attenuates TNFα-dependent ICAM1 expression in the cultured human umbilical vein endothelial cells (HUVECs), by targeting the TNFα-PI3K-NF-κB-ICAM1 pathway.Materials and Methods: Cultured HUVECs were treated with pro-inflammatory and pro-oxidative cytokine TNFα, to induce ICAM1 mRNA level and protein expression on HUVECs cell surface as documented by northern and western blot, respectively. The effect of varying NDGA concentrations was examined on TNFα-stimulated ICAM1 expression and monocyte attachment assay.Results: Pre-TNFα-NDGA treatment of HUVECs moderated TNFα-dependent ICAM1 expression and monocyte attachment on vascular endothelium by inhibiting the PI3K-NF-κB-ICAM1 signaling pathway.Conclusion: In this study, the NDGA anti-inflammatory and anti-adhesion essence is elucidated via impaired cytoplasm to nucleus  translocation of pro-oxidative and pro-inflammatory transcription factor NF-κB, moderating the ICAM1 expression and monocyte attachment.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Human umbilical vein endothelial cells (HUVECs) TNFα Intercellular adhesion molecule, 1 (ICAM1) NDGA PI3K NF, κB</keyword>
				<start_page>260</start_page>
				<end_page>271</end_page>
				<web_url>https://ajp.mums.ac.ir/article_26225.html</web_url>
			<author_list><author>
				<first_name>Tapan Kumar</first_name>
				<middle_name></middle_name>
				<last_name>Mukherjee</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>tapan400@gmail.com</email>
				<code>115129</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Amity Institute of Biotechnology, Amity University, Major Arterial Road, Action Area II-36, 37, 38, Rajarhat, New Town, Kolkata 700156, West Bengal, India.</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Parth</first_name>
				<middle_name></middle_name>
				<last_name>Malik</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>parthmalik1986@gmail.com</email>
				<code>115130</code>
				<coreauthor>No</coreauthor>
				<affiliation>Swarrnim Startup and Innovation University, Bhoyan-Rathod, Gandhinagar, Gujarat</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Raj</first_name>
				<middle_name></middle_name>
				<last_name>Singh</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>dr.rajsingh09@gmail.com</email>
				<code>115131</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Biotechnology, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Haryana, India.</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Vishal</first_name>
				<middle_name></middle_name>
				<last_name>Patel</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>vishalpatel2003@yahoo.co.in</email>
				<code>115132</code>
				<coreauthor>No</coreauthor>
				<affiliation>Institute of Biotechnology, Amity University, Noida 201301, Uttar Pradesh, India</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Raman</first_name>
				<middle_name></middle_name>
				<last_name>Kumar</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>ramankumar4@gmail.com</email>
				<code>115133</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Biotechnology, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Haryana, India.</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Wortmannin exhibits anticancer activity in oral cancer cell line by targeting PI3K, AKT and mTOR pathway</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Research Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective: Although the molecular mechanism by which wortmannin exerts its anticancer properties in solid tumors is not fully understood, particularly in the context of oral cancer where research is scarce, this study seeks to explore how wortmannin disrupts the PI3K pathway, consequently affecting the proliferation and apoptosis of human oral cancer cells.Materials and Methods: In-silico investigation included drug-likeness predictions, oral cancer and wortmannin targets, Protein-Protein Interactions (PPI), hub gene analysis, the top 10 KEGG pathways, Gene Ontology (GO), and molecular docking tests. In vitro experiments examined Viability Assay, apoptosis, cell cycle, Reactive Oxygen Species ROS and MMP levels, and gene expression.Results: Twenty commonly expressed genes affect cell proliferation, apoptosis, the PI3K signaling system, and the cell cycle as a result of in-silico analysis. Top 10 genes include mTOR, MAPK1, PIK3CA, PTGS2, MAPK8, AR, TERT, PIK3CB, PARP1, and PIK3CG. Wortmannin may treat oral cancer by targeting the PI3K/AKT signaling pathway, which is linked to these genes. In vitro tests showed anti-proliferative effects (IC50 = 3.6 ± 1 µM and IC25 = 1.8 ± 1 µM), late-stage apoptosis, reduced ROS, and MMP changes. Wortmannin downregulated mTOR, PIK3CA, ERK, PTEN, STAT3, and AKT. In addition, BCL2 and cMYC levels decreased and BAD and BAK expression increased.Conclusion: The in-silico strategy used in this study establishes the framework for cancer therapeutic research. This research has revealed wortmannin&#039;s ability to treat oral cancer in clinical settings. To validate in-silico and in-vitro findings, more assays and in-vivo research are needed.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Oral cancer Wortmannin In, silico analysis PI3K/AKT Apoptosis Cell cycle</keyword>
				<start_page>272</start_page>
				<end_page>292</end_page>
				<web_url>https://ajp.mums.ac.ir/article_26226.html</web_url>
			<author_list><author>
				<first_name>GAURI</first_name>
				<middle_name>M.</middle_name>
				<last_name>KUMBHAR</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>gaurikumbhar764@gmail.com</email>
				<code>115135</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Oral Pathology. Dr. D. Y. Patil Dental College and Hospital. Dr. D. Y. Patil Vidyapeeth, (Deemed to Be University). Sant Tukaram Nagar, Pimpri, Pune. India.</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Poonam</first_name>
				<middle_name></middle_name>
				<last_name>Suryawanshi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>poonam.suryawanshi@dpu.edu.in</email>
				<code>115136</code>
				<coreauthor>No</coreauthor>
				<affiliation>Central Research Facility. Dr. D. Y. Patil Medical College, Hospital and Research Centre. Dr. D. Y. Patil Vidyapeeth, (Deemed to Be University). Sant Tukaram Nagar, Pimpri, Pune. India.</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>VAIBHAV</first_name>
				<middle_name>SUNIL</middle_name>
				<last_name>LADKE</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>drvaibhavladke@gmail.com</email>
				<code>115137</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Tissue Culture &amp; Cell Biology Lab. Central Research Facility. Dr. D. Y. Patil Medical College, Hospital and
Research Centre. Dr. D. Y. Patil Vidyapeeth, (Deemed to Be University). Sant Tukaram Nagar, Pimpri, Pune.
India. 411018</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Suppressive effect of lemon (Citrus limon L. Burm. f.) extract toward pro-tumor immune response in DMBA-induced carcinogenesis mouse</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Research Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective: Cancer is a worldwide health issue which recognized as a chronic condition resulting from the unregulated growth of abnormal cells. Breast cancer has overtaken lung cancer as the most often diagnosed malignancy among all genders, with a projected three million new cases by 2040. Many treatment options are available, however, latest therapies are associated with undesirable side effects. Citrus limon is among the medicinal plants recognized to have immunomodulatory properties. This research aimed to examine the immunomodulatory effect of C. limon extract (CLE) in 7,12-Dimethylbenz[a]anthracene (DMBA)-induced carcinogenesis mice.Materials and Methods: The treatment group consisted of four subgroups: a vehicle control group, a DMBA induction group, a CLE 50 group, and a CLE 200 group. Flow cytometry was used to assess the proportions of the following cell populations: Gr-1+, CD68+IL-17+, CD68+TNF-α+, NK1.1+, CD4+CD25+, and CD4+CD25+CD62L+.Results: In this study, we discovered that CLE reduces the number of immune system profiles to normal levels, including granulocytes, macrophages, natural killer cells, and effector T cells, while increasing the population of regulator T cells to normal levels. Moreover, the absorption, distribution, metabolism, excretion, and toxicity (ADMET) evaluation showed that several significant CLE compounds meet the drug-like requirements.Conclusion: This research revealed that CLE might be developed as a supplemental or additional cancer treatment.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Adaptive immunity, Cancer, Citrus limon, Immunomodulatory, Innate immunity</keyword>
				<start_page>293</start_page>
				<end_page>304</end_page>
				<web_url>https://ajp.mums.ac.ir/article_26348.html</web_url>
			<author_list><author>
				<first_name>Wira Eka</first_name>
				<middle_name></middle_name>
				<last_name>Putra</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>wep.cendekia@gmail.com</email>
				<code>115663</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Biotechnology Study Program, Department of Applied Sciences, Faculty of Mathematics and Natural Sciences, Universitas Negeri Malang, East Java, Indonesia.</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Chalissa</first_name>
				<middle_name></middle_name>
				<last_name>Nuruzzulfa</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email></email>
				<code>117170</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Biology, Faculty of Mathematics and Natural Sciences, Brawijaya University, East Java, Indonesia</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Dea Esaayu</first_name>
				<middle_name></middle_name>
				<last_name>Mahabella</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email></email>
				<code>117171</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Biology, Faculty of Mathematics and Natural Sciences, Brawijaya University, East Java, Indonesia</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Ramdhani Faradilla</first_name>
				<middle_name></middle_name>
				<last_name>Intania Nuraıda</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email></email>
				<code>117172</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Biology, Faculty of Mathematics and Natural Sciences, Brawijaya University, East Java, Indonesia</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Arief</first_name>
				<middle_name></middle_name>
				<last_name>Hıdayatullah</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email></email>
				<code>117173</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Democratic Governance and Poverty Reduction Unit, United Nations Development Programme, Eijkman-RSCM Building, Jakarta, Indonesia.</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Muhaimin</first_name>
				<middle_name></middle_name>
				<last_name>Rifa’i</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email></email>
				<code>117174</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Biology, Faculty of Mathematics and Natural Sciences, Brawijaya University, East Java, Indonesia</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>The modulatory role of 6-gingerol-rich portion of ginger on brain oxidative stress, inflammation and neurotransmission in chronic unpredicted mild stress-induced depressed male Wistar rats</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Research Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective: This study was designed to investigate the effect of 6-gingerol-rich extract of ginger (6-GIRPOG) on oxidative stress, inflammation and neurotransmission in chronic unpredicted mild stress (CUMS)-induced depressed male Wistar rats.Materials and Methods: Twenty-five (25) male Wistar rats in total were divided into five groups at random (n = 5 in each group). The control group received 0.5 ml of normal saline, CUMS rats were only exposed to CUMS daily, CUMS + fluoxetine rats were exposed to CUMS and orally received 10 mg/kg per body weight of fluoxetine daily, CUMS + 6-GIRPOG (100) and CUMS + 6-GIRPOG (200) rats were exposed to CUMS and orally received 100 and 200 mg/kg body weight of 6-GIRPOG respectively (daily). Exposure to CUMS and treatment were carried out for a period of 21 days, after which light and dark box test, sucrose splash test, and forced swim test were conducted to assess the behavioral functions. The rats were then euthanized and their brain samples were collected for biochemical analysisResults: The exposure to CUMS caused behavioral alterations as well as a significant (p&lt;0.05) decrease in the levels of brain-derived neurotrophic factor (BDNF), glutamate, reduced glutathione (GSH), and activities of superoxide dismutase (SOD). Furthermore, the exposure to CUMS caused a statistically significant rise (p&lt;0.05) in the brain norepinephrine, cortisol, nuclear factor kappa-B (NFK-B), tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and IL-6. However, the administration of both 100 and 200 mg/kg of 6-GIRPOG effectively reversed these behavioral and biochemical changes.Conclusion: Consequently, the study reveals the role of 6-GIRPOG in ameliorating CUMS-induced depression and brain damage via antioxidative, anti-inflammatory, and neurotransmission modulatory mechanisms.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Behavioral Antioxidant Anti, inflammatory Biochemical Neurotransmission</keyword>
				<start_page>305</start_page>
				<end_page>317</end_page>
				<web_url>https://ajp.mums.ac.ir/article_26364.html</web_url>
			<author_list><author>
				<first_name>Maryam</first_name>
				<middle_name>Tayo</middle_name>
				<last_name>Ayinla</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>gazmark@unilorin.edu.ng</email>
				<code>115715</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Physiology, University of Ilorin, Ilorin, Nigeria</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Abraham</first_name>
				<middle_name>Olufemi</middle_name>
				<last_name>Asuku</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>asufem2017@gmail.com</email>
				<code>115716</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Flamingo street
Stadium road</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Evaluation of the monotherapy effect of crocin on mild-to-moderate diabetic retinopathy: A randomized clinical trial</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Research Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective: Diabetic retinopathy (DR) is asymptomatic and can lead to severe and irreversible vision loss if not treated promptly. The aim of this study was to evaluate the efficacy of crocin in mild-to-moderate DR patients whose macular center was not involved according to the early treatment diabetic retinopathy study (ETDRS) criteria.Materials and Methods: Forty patients with primary DR without involvement of the macular center were enrolled and randomized into crocin 15 mg/day and placebo groups for 3 months.  At the beginning and 3 months later, best corrected visual acuity (BCVA), fasting blood sugar (FBS) and HbA1c were measured and the thickness of areas around the macula was determined. After three months, the patients were examined by an ophthalmologist and the required specialized tests were performed.Results: The mean age of the participants was 47-71 years that were 27 males and 13 females. In the intragroup comparison, the thickness around the macula was significantly reduced in the crocin group (p=0.001) compared to placebo group (p=0.67). In comparison between groups, the mean thickness of the areas around the macula at the beginning and end of the study was significantly different (p=0.046). BCVA and FBS were not significantly different after 3 months between groups. HbA1C was significantly reduced (p=0.004) in the crocin group. In this study, no specific complication due to drug use was reported.Conclusion: Based on our findings, crocin was effective in reducing the thickness of the areas around the macula in mild-to-moderate DR. It is suggested that crocin can be considered an effective supplementary drug in preventing the progression and an adjuvant therapy for DR.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Crocin, Diabetic retinopathy, Best corrected visual acuity Macular thickness, Retinal thickness</keyword>
				<start_page>318</start_page>
				<end_page>329</end_page>
				<web_url>https://ajp.mums.ac.ir/article_26305.html</web_url>
			<author_list><author>
				<first_name>Sayed Ahmad</first_name>
				<middle_name></middle_name>
				<last_name>Mohajeri</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mohajeria@mums.ac.ir</email>
				<code>115470</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Department of Pharmacodynamics and Toxicology, Faculty of Pharmacy, Mashhad University of Medical Science, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Comparison of Hibiscus sabdariffa L. extract and hydrochlorothiazide as adjuncts to Valsartan in managing hypertension in type 2 diabetic nephropathy: A randomized clinical trial</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Research Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective: The effects of Hibiscus sabdariffa L. extract (HSE) as a supplemental therapy with valsartan for type 2 diabetic patients with nephropathy and its underlying biological functions were investigated in this study.Materials and Methods: This clinical trial took place in Gorgan, Iran with 70 diabetic nephropathy patients who had hypertension. The participants were divided into two groups: The HSE group which received 500 mg HSE along with valsartan 40 mg twice daily over three months (n=35) and the control group which received valsartan plus hydrochlorothiazide 12.5 mg (n=35). The study measured blood pressure levels with additional assessments of microalbuminuria, proteinuria, and glomerular filtration rate (GFR) alongside lipid profile analysis, and hemoglobin A1c (HbA1c), fasting blood glucose (FBS), and electrolyte tests. Molecular docking simulations tested HSE compounds as potential inhibitors of sodium-glucose cotransporter-2 (SGLT2), dipeptidyl peptidase-4 (DPP-4), glucagon-like peptide-1 (GLP-1), and Receptor for advanced glycation end products (RAGE).Results: Both groups showed improvements, but HSE had a greater impact on kidney function and lipid levels, while control group was more effective in lowering blood pressure and improving glucose metabolism. Docking analysis revealed that cyanidin 3-O-beta-D-sambubioside and tiliroside strongly interacted with targets, suggesting a role in blood glucose regulation and insulin secretion.Conclusion: HSE demonstrates the potential to help type 2 diabetic nephropathy patients by modifying renin-angiotensin-aldosterone system activity carbohydrate digestion processes and lipid metabolism which reduces diabetic complications risks.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Hibiscus sabdariffa L, Diabetes Mellitus, Molecular docking</keyword>
				<start_page>330</start_page>
				<end_page>341</end_page>
				<web_url>https://ajp.mums.ac.ir/article_26575.html</web_url>
			<author_list><author>
				<first_name>Hassan</first_name>
				<middle_name></middle_name>
				<last_name>Mirzaei</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>hmirzaei@goums.ac.ir</email>
				<code>116674</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Golestan University of Medical Sciences</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Ayesheh</first_name>
				<middle_name></middle_name>
				<last_name>Enayati</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>enayati_phyto@yahoo.com</email>
				<code>116675</code>
				<coreauthor>No</coreauthor>
				<affiliation>Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Maryam</first_name>
				<middle_name></middle_name>
				<last_name>Kiani</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>kiani.m94@gmail.com</email>
				<code>116676</code>
				<coreauthor>No</coreauthor>
				<affiliation>1Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Somayeh</first_name>
				<middle_name></middle_name>
				<last_name>Ghorbani</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>s.ghorbani.gh@gmail.com</email>
				<code>116677</code>
				<coreauthor>No</coreauthor>
				<affiliation>1Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Gokhan</first_name>
				<middle_name></middle_name>
				<last_name>Zengin</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>gokhanzengin@selcuk.edu.tr</email>
				<code>116678</code>
				<coreauthor>No</coreauthor>
				<affiliation>Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Saeid</first_name>
				<middle_name></middle_name>
				<last_name>Amirkhanlou</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>drsam74ir@ymail.com</email>
				<code>116679</code>
				<coreauthor>No</coreauthor>
				<affiliation>Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Evaluation of nano-curcumin oral formulation efficacy in prevention of chemotherapy-induced adverse reactions in metastatic colorectal cancer patients</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Research Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective: The aim of the present study is to evaluate the effectiveness of oral formulation of nano-curcumin in prevention of some chemotherapy-induced adverse reactions.Materials and Methods: In this study, 84 patients with metastatic colorectal cancer were randomly assigned into the nano-curcumin (40 mg capsule) or placebo groups, receiving treatments three times daily, beginning the first day to the end of the sixth cycle of chemotherapy. To investigate various adverse events, including hematologic adverse reactions, diarrhea, hand-foot syndrome (HFS) and neuropathy, the criteria of National Cancer Institute Common Terminology for Adverse Events (NCI-CTCAE) version 5 were implemented after the third and sixth course.Results: The CTCAE peripheral neuropathy score was significantly different between the two groups at the end of the 6th course (p=0.029) but not the third course (p=0.157). No significant response was observed for neutropenia, anemia, thrombocytopenia, HFS, or diarrhea at the end of both third (P=0.267, 0.258, 0.933, 0.377, and 0.811, respectively) and 6th courses (p=0.456, 0.645, 0.772, 0.34, and 0.114, respectively).Conclusion: Nano-curcumin in dose of 40 mg thrice daily was not effective in prevention of neuropathy, HFS and hematologic adverse reactions induced by XELOX/FOLFOX-6 regimens. Further research with larger sample size on different nano-curcumin dosing schedules is suggested.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Metastatic colorectal cancer Nanocurcumin, Chemotherapy toxicity, Cancer progression, FOLFOX/XELOX±Bevacizumab</keyword>
				<start_page>342</start_page>
				<end_page>355</end_page>
				<web_url>https://ajp.mums.ac.ir/article_26317.html</web_url>
			<author_list><author>
				<first_name>Mahdi</first_name>
				<middle_name></middle_name>
				<last_name>Jannati Yazadan Abad</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>jannatim901@gmail.com</email>
				<code>115519</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Abolghasem</first_name>
				<middle_name></middle_name>
				<last_name>Allahyari</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>allahyaria@mums.ac.ir</email>
				<code>115520</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Hematology-Oncology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mostafa</first_name>
				<middle_name></middle_name>
				<last_name>Kamandi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>kamandim@mums.ac.ir</email>
				<code>115521</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Hematology-Oncology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Omid</first_name>
				<middle_name></middle_name>
				<last_name>Arasteh</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>arasteho@mums.ac.ir</email>
				<code>115522</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mehdi</first_name>
				<middle_name></middle_name>
				<last_name>Varmaghani</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mehdivarmaghani@gmail.com</email>
				<code>115523</code>
				<coreauthor>No</coreauthor>
				<affiliation>Social Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. 
Department of Management Sciences and Health Economics, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Hedyieh</first_name>
				<middle_name></middle_name>
				<last_name>Karbasforooshan</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>hedyiehk72@gmail.com</email>
				<code>115524</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mahmoud Reza</first_name>
				<middle_name></middle_name>
				<last_name>Jaafari</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>jafarimr@mums.ac.ir</email>
				<code>115525</code>
				<coreauthor>No</coreauthor>
				<affiliation>Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Hamidreza</first_name>
				<middle_name></middle_name>
				<last_name>Kheradmand</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>hamidreza.kheradmand@gmail.com</email>
				<code>115526</code>
				<coreauthor>No</coreauthor>
				<affiliation>Mashhad University of Medical Sciences, School of Medicine, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Abolfazl</first_name>
				<middle_name></middle_name>
				<last_name>Eftekhari</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>ablfzl1993@gmail.com</email>
				<code>115527</code>
				<coreauthor>No</coreauthor>
				<affiliation>Babol University of Medical Sciences, School of Medicine, Babol, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Sepideh</first_name>
				<middle_name></middle_name>
				<last_name>Elyasi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>elyasis@mums.ac.ir</email>
				<code>115528</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Pharmacotherapy</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Vitex agnus-castus extract improved the endocrine profile and important gene expression in rat ovaries with polycystic ovary syndrome</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Research Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective: The beneficial effect of Vitex agnus-castus on the female endocrine system has been reported. This study examines the impact of Vitex extract (VE) on the serum anti-Mullerian hormone (AMH), sex hormones, and P450arom, AMH, and CTRP6 gene expression in the ovaries of a rat model of PCOS.Materials and Methods: Thirty-two rats with regular estrous cycles were enrolled as controls, polycystic ovary syndrome (PCOS), and two treatment groups. PCOS was induced by estradiol valerate. The treatment groups (T1 &amp;T2) received VE (150 or 200 mg/kg body weight, respectively) for 30 days following PCOS induction. Serum and left ovary were used to assess hormone levels and P450arom, AMH, and CTRP6 gene expression.Results: In the T2 group, a significant decrease in estradiol (E2, testosterone, and AMH levels (p=0.028) was observed with no significant change in DHEA (p=0.967) in comparison with the PCOS group. AMH in the serum was significantly higher in the PCOS group than in all the other groups (p=0.021). The level of progesterone was not considerably changed between treatments and the PCOS group (p=0.11).  The expression of P450arom in the T2 group was significantly higher than the PCOS group (p=0.003) and had no significant difference from the control (p=0.200). The expression of AMH (p=0.003) and CTRP6 was significantly (p=0.0001) higher in the ovaries of the PCOS group compared to other groups, and consumption of the extract improved the evaluated parameters significantly.Conclusion: The endocrine profile and gene expression were improved in the rat ovary following administration of VE, and therefore, the therapeutic effect of VE may be expected in PCOS.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>AMH PCOS P450arom CTRP6 Vitex agnus, castus</keyword>
				<start_page>356</start_page>
				<end_page>366</end_page>
				<web_url>https://ajp.mums.ac.ir/article_26622.html</web_url>
			<author_list><author>
				<first_name>Mahtab</first_name>
				<middle_name></middle_name>
				<last_name>Abbaszadeh</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>mahtababaszadeh4791@gmail.com</email>
				<code>116872</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Physiology, School of Veterinary Medicine, Shiraz University, Shiraz</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Gholamali</first_name>
				<middle_name></middle_name>
				<last_name>Jelodar</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>jelodar@shirazu.ac.ir</email>
				<code>116873</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Shiraz University</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Saeed</first_name>
				<middle_name></middle_name>
				<last_name>Hossainzadeh</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>hosseinzadeh@shirazu.ac.ir</email>
				<code>116874</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department Food hygiene, School of Veterinary Medicine, Shiraz University, Shiraz</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Azam</first_name>
				<middle_name></middle_name>
				<last_name>Salmani</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>shymas042@gmail.com</email>
				<code>116875</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Physiology, School of Veterinary Medicine, Shiraz University, Shiraz</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Dexamethasone-induced hepatic biochemical and pathological damages are attenuated by Cynodon dactylon extract containing hexadecanoic acid via reduction of glucose uptake: In vitro and in vivo studies</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Research Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective: The protective effects of ethanolic extract of Cynodon dactylon (CD) on dexamethasone (DEX)-induced hepatic injuries were investigated.Materials and Methods: Following GC-MS phytochemical analyses of the extract, in vivo studies were conducted in male rats which were grouped as: control, dexamethasone (8mg/kg, intraperitoneally), DEX+CD (100, 200 and 400 mg/kg, orally), CD 400 and DEX+metformin (MET, 300mg/kg, orally) for 15 days. The in vitro studies were performed in HepG2 cells that grouped as: Control, DEX (1 µM), DEX+CD (0.1, 0.5 and 1 mg/ml), CD 0.5 mg/ml, and DEX+MET (500 µM). Cell viability and animal weight changes were recorded. Following the study period, biochemical and histopathological analyses were conducted on hepatic tissue and HepG2 cells.Results: Findings revealed that CD extract does have concentration-dependent free radical-scavenging activity, and it possesses phenols and flavonoids contents. The most abundant compound of the CD extract was n-hexadecanoic acid. The DEX-induced hepatic functional enzymes and lactate dehydrogenase levels were significantly (p&lt;0.05) reduced in both models. Moreover, the DEX-induced oxidative stress was improved by CD extract (45%). The DEX-elevated blood glucose (20%) and triglycerides (60%) were reduced in CD-treated animals. The DEX-generated hepatic macrovesicles and lipid droplets in HepG2 cells were reduced.Conclusion: These results suggest that CD extract could be an effective compound for protection from DEX-induced hepatic injuries.]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Dexamethasone, Hepatic injuries, Hypolipidemic effect, glucose uptake</keyword>
				<start_page>367</start_page>
				<end_page>385</end_page>
				<web_url>https://ajp.mums.ac.ir/article_26623.html</web_url>
			<author_list><author>
				<first_name>Sadaf</first_name>
				<middle_name></middle_name>
				<last_name>Mottaghian</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>sadafy.m.97@gmail.com</email>
				<code>116876</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Pharmacology and Toxicology, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Ayshin</first_name>
				<middle_name></middle_name>
				<last_name>Khalilarya</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>ayshinkhalilarya@gmail.com</email>
				<code>116877</code>
				<coreauthor>No</coreauthor>
				<affiliation>Experimental &amp; Applied Pharmaceutical Sciences Research Center, Urmia University of Medical Sciences, Urmia, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Hassan</first_name>
				<middle_name></middle_name>
				<last_name>Malekinejad</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>hassanmalekinejad@yahoo.com</email>
				<code>116878</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>a Experimental &amp; Applied Pharmaceutical Sciences Research Center, Urmia University of Medical Sciences, Urmia, Iran;
b Department of Pharmacology and Toxicology, School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article><article>
				<language>en</language>
				<article_id_issn></article_id_issn>
				<article_id_issn_online></article_id_issn_online>
				<article_id_pubmed></article_id_pubmed>
				<article_id_pii></article_id_pii>
				<article_id_doi></article_id_doi>
				<article_id_iranmedex></article_id_iranmedex>
				<article_id_magiran></article_id_magiran>
				<article_id_sid></article_id_sid>
				<title_fa></title_fa>
				<title>Protective effect of pomegranate seed oil against lead acetate-induced toxicity on the hippocampus and bone marrow in rats</title>
				<subject_fa></subject_fa>
				<subject></subject>
				<content_type_fa></content_type_fa>
				<content_type>Original Research Article</content_type>
				<abstract_fa><![CDATA[]]></abstract_fa>
				<abstract><![CDATA[Objective: Lead poisoning is one of the oldest occupational and environmental diseases in the world. It can enter the body by being absorbed in water, air, and food. Oxidative stress is one of the mechanisms responsible for lead toxicity. Anti-inflammatory and antioxidant properties are the primary effects of pomegranate seed oil (PSO). This research is designed to determine the impact of PSO on damage to the hippocampus, bone, and bone marrow in rats triggered by lead acetate.Materials and Methods: Thirty-two adult male rats were subjected to this study. The animals were divided into four groups at random after they had acclimated. The control group received 1 ml/kg of normal saline for 21 days. Animals in the Pb group received 500 ppm of lead acetate in drinking water for 21 days. Pb+ PSO 0.4 ml/kg and Pb+ PSO 0.8 ml/kg received 0.4 or 0.8 ml/kg of PSO intraperitoneally, concomitant with exposure to lead acetate for 21 days. Blood, bone, bone marrow, and hippocampus samples were taken after the treatment for measuring malondialdehyde (MDA), thiol content and superoxide dismutase (SOD).  Results: Our results revealed that 0.8 ml/kg of PSO significantly decreased malondialdehyde in bone marrow, serum, and hippocampus. It also could increase thiol in serum and superoxide dismutase in bone marrow.Conclusion: PSO could protect against lead-induced damage in bone, bone marrow, and hippocampus of treated animals through reduction of oxidative stress. ]]></abstract>
				<keyword_fa></keyword_fa>
				<keyword>Pomegranate seed oil, Lead acetate, Oxidative stress, Hippocampus, bone marrow</keyword>
				<start_page>386</start_page>
				<end_page>397</end_page>
				<web_url>https://ajp.mums.ac.ir/article_26495.html</web_url>
			<author_list><author>
				<first_name>Mohaddeseh Sadat</first_name>
				<middle_name></middle_name>
				<last_name>Alavi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>alavimhd@mums.ac.ir</email>
				<code>116311</code>
				<coreauthor>No</coreauthor>
				<affiliation>Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>azar</first_name>
				<middle_name></middle_name>
				<last_name>Hosseini</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>hoseiniaz@mums.ac.ir</email>
				<code>116312</code>
				<coreauthor>No</coreauthor>
				<affiliation>Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Fereshte</first_name>
				<middle_name></middle_name>
				<last_name>Torabi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>torabif991@mums.ac.ir</email>
				<code>116313</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Anatomy and Cell Biology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mitra</first_name>
				<middle_name></middle_name>
				<last_name>Rayati banadkooki</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>raeiatibm971@mums.ac.ir</email>
				<code>116314</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Zahra</first_name>
				<middle_name></middle_name>
				<last_name>Taghadosi</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>taghadosiz971@mums.ac.ir</email>
				<code>116315</code>
				<coreauthor>No</coreauthor>
				<affiliation>Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author><author>
				<first_name>Mohammad Taher</first_name>
				<middle_name></middle_name>
				<last_name>Boroushaki</last_name>
				<suffix></suffix>
				<first_name_fa></first_name_fa>
				<middle_name_fa></middle_name_fa>
				<last_name_fa></last_name_fa>
				<suffix_fa></suffix_fa>
				<email>boroushakimt@mums.ac.ir</email>
				<code>116316</code>
				<coreauthor>Yes</coreauthor>
				<affiliation>Pharmacology</affiliation>
				<affiliation_fa></affiliation_fa>
				 </author></author_list>
				</article>
			</articleset>
			</journal>